# Diquafosol vs Hyaluronic Acid for Diabetic Dry Eye

> **NCT05682547** · NA · COMPLETED · sponsor: **He Eye Hospital** · enrollment: 99 (actual)

## Conditions studied

- Diabetic Eye Problems

## Interventions

- **DRUG:** 3% Diquafosol tetrasodium
- **DRUG:** 0.1% hyaluronate

## Key facts

- **NCT ID:** NCT05682547
- **Lead sponsor:** He Eye Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2025-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05682547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05682547, "Diquafosol vs Hyaluronic Acid for Diabetic Dry Eye". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05682547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*